{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"71","value":"33"},{"groupId":"OG001","lowerLimit":"0","upperLimit":"40","value":"14"},{"groupId":"OG002","lowerLimit":"7","upperLimit":"38","value":"22"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}],"units":"Participants"}],"title":"BuCy"},{"categories":[{"measurements":[{"groupId":"OG001","lowerLimit":"17","upperLimit":"69","value":"43"},{"groupId":"OG002","lowerLimit":"23","upperLimit":"52","value":"37"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"43"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}],"units":"Participants"}],"title":"CBV"},{"categories":[{"measurements":[{"groupId":"OG002","lowerLimit":"0","upperLimit":"0","value":"0"},{"groupId":"OG004","lowerLimit":"6","upperLimit":"80","value":"43"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"7"}],"units":"Participants"}],"title":"VCp"},{"categories":[{"measurements":[{"groupId":"OG003","lowerLimit":"2","upperLimit":"41","value":"22"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"18"},{"groupId":"OG004","value":"0"}],"units":"Participants"}],"title":"Mel120"},{"categories":[{"measurements":[{"groupId":"OG003","lowerLimit":"3","upperLimit":"22","value":"13"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"47"},{"groupId":"OG004","value":"0"}],"units":"Participants"}],"title":"Mel200"},{"categories":[{"measurements":[{"groupId":"OG004","lowerLimit":"0","upperLimit":"0","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"}],"units":"Participants"}],"title":"CyTtCp"},{"categories":[{"measurements":[{"groupId":"OG004","lowerLimit":"0","upperLimit":"100","value":"50"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"2"}],"units":"Participants"}],"title":"TtC1500"}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"65"},{"groupId":"OG004","value":"11"}],"units":"Participants"}],"description":"Assessed using the product-limit based Kaplan Meier method. Additionally, a 95% confidence interval of the distribution will be computed.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients diagnosed with and treated for acute myeloid leukemia or acute lymphoblastic leukemia","id":"OG000","title":"Acute Leukemia"},{"description":"Patients diagnosed with and treated for Hodgkin Lymphoma","id":"OG001","title":"Hodgkin Lymphoma"},{"description":"Patients diagnosed with and treated for Non-Hodgkin Lymphoma","id":"OG002","title":"Non-Hodgkin Lymphoma"},{"description":"Patients diagnosed with or treated for multiple myeloma or amyloidosis","id":"OG003","title":"MM/Amyloid"},{"description":"Patients diagnosed with and treated for a solid tumor","id":"OG004","title":"Solid Tumors"}],"paramType":"NUMBER","populationDescription":"Each disease strata presents PFS for each conditioning regimen defined in the protocol","reportingStatus":"POSTED","timeFrame":"From the date of transplantation to the date of first observed disease progression or death due to any cause, assessed up to 12 years","title":"Progression-free Survival (PFS) Distribution of Patients With HL, NHL, and MM for Each Disease-specific High-dose Therapy Regimen, Estimate Provided for 10-yr PFS (Median Follow-up Time in Survivors)","type":"PRIMARY","unitOfMeasure":"Proportion of participants"}